These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. In vitro assessment of cellular immunity to Rauscher leukemia virus. Mortensen RF, Ceglowski WS, Friedman H. J Immunol; 1973 Sep; 111(3):657-60. PubMed ID: 4741293 [No Abstract] [Full Text] [Related]
4. The development of specific cellular and humoral immunity in mice infected with Rauscher leukemia virus as neonates or adults. McCoy JL, Fefer A, Ting RC, Glynn JP. Cancer Res; 1972 Aug; 32(8):1671-8. PubMed ID: 4339747 [No Abstract] [Full Text] [Related]
5. Immunodepressive effect of Rauscher leukemia virus on antinuclear antibody formation in New Zealand black mice. Siegel BV, Brown M, Morton JI. J Natl Cancer Inst; 1972 Jan; 48(1):159-63. PubMed ID: 4568962 [No Abstract] [Full Text] [Related]
11. [Mechanism of the modifying effect of neuraminidase of the influenza virus on the development of Rauscher leukemia]. Novichenko NL, Struk VI. Eksp Onkol; 1984 Jan; 6(3):29-32. PubMed ID: 6499739 [Abstract] [Full Text] [Related]
13. Are the neoantigens induced by leukemogenic viruses particular to cancer cells? Mathé G. Bibl Haematol; 1968 Jan; 30():43-7. PubMed ID: 4877327 [No Abstract] [Full Text] [Related]
14. Stimulation of murine lymphocytes by Rauscher leukemia virus in vitro. Bubbers JE, Elder JH, Dixon FJ. J Immunol; 1980 Jan; 124(1):388-94. PubMed ID: 7350233 [Abstract] [Full Text] [Related]
19. Immunogenicity of subcellular fractions and molecular species of MuLV-induced tumors. II. Stimulation of syngeneic antitumor cell-mediated immune responses by subcellular fractions and molecular species of the Rauscher-virus-induced RBL5 tumor. Kobrin BJ, Naor D, Klein BY. J Immunol; 1981 May; 126(5):1874-82. PubMed ID: 6260859 [No Abstract] [Full Text] [Related]